Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinblastine and Methotrexate in Children With Desmoid Tumor
NCT00003019Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Aug 1997
- Primary completion
- Jul 2003
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
Phase 2, open-label, single-arm trial of vinblastine and methotrexate in desmoid tumor, sponsored by Children's Oncology Group. Primary endpoint: Event Free Survival. Started Aug 1997; status: completed.
02
Drugs
vinblastinemethotrexate
03
Conditions
desmoid tumor
Beyond the preview
Go deeper on NCT00003019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003019.